Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | STE/STE11/ASK protein kinase | 0.00810777 | 0.00606673 | 0.000154654 |
Echinococcus multilocularis | tyrosine protein kinase Blk | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0112272 | 0.0220802 | 0.0220802 |
Trichomonas vaginalis | N-myristoyl transferase, putative | 0.201725 | 1 | 1 |
Echinococcus granulosus | tyrosine kinase|tyrosine protein kinase Fyn | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus multilocularis | tyrosine protein kinase Abl | 0.0112272 | 0.0220802 | 0.0220802 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0112272 | 0.0220802 | 0.0220802 |
Schistosoma mansoni | tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus granulosus | 3'partial|tyrosine protein kinase Fgr | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus multilocularis | tyrosine protein kinase lyn tyrosine protein kinase blk | 0.0112272 | 0.0220802 | 0.0220802 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Loa Loa (eye worm) | N-myristoyltransferase 2 | 0.201725 | 1 | 1 |
Echinococcus multilocularis | tyrosine protein kinase Srms | 0.0112272 | 0.0220802 | 0.0220802 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.00810777 | 0.00606673 | 0.00606673 |
Echinococcus multilocularis | tyrosine protein kinase Fgr | 0.0112272 | 0.0220802 | 0.0220802 |
Trypanosoma brucei | N-myristoyl transferase, putative | 0.201725 | 1 | 1 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0112272 | 0.0220802 | 0.0220802 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Echinococcus granulosus | glycylpeptide N tetradecanoyltransferase | 0.201725 | 1 | 1 |
Schistosoma mansoni | N-myristoyltransferase | 0.201725 | 1 | 1 |
Echinococcus granulosus | tyrosine protein kinase Blk | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0112272 | 0.0220802 | 0.0220802 |
Trypanosoma brucei | N-myristoyltransferase | 0.201725 | 1 | 1 |
Echinococcus multilocularis | glycylpeptide N tetradecanoyltransferase | 0.201725 | 1 | 1 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.0249182 | 0.0923627 | 0.0923627 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0112272 | 0.0220802 | 0.0220802 |
Entamoeba histolytica | glycylpeptide N-tetradecanoyltransferase, putative | 0.201725 | 1 | 1 |
Brugia malayi | Neuronal symmetry protein 1 | 0.0249182 | 0.0923627 | 0.0718694 |
Echinococcus multilocularis | tyrosine protein kinase Fyn | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus multilocularis | tyrosine protein kinase Btk29A | 0.0112272 | 0.0220802 | 0.0220802 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Echinococcus granulosus | tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Onchocerca volvulus | 0.0112272 | 0.0220802 | 0.5 | |
Echinococcus granulosus | tyrosine protein kinase Btk29A | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus multilocularis | tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Onchocerca volvulus | 0.0112272 | 0.0220802 | 0.5 | |
Toxoplasma gondii | calcium dependent protein kinase CDPK8 | 0.00692598 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0112272 | 0.0220802 | 0.0162634 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.0249182 | 0.0923627 | 0.0923627 |
Schistosoma mansoni | tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus multilocularis | tyrosine protein kinase Fps85D | 0.0112272 | 0.0220802 | 0.0220802 |
Plasmodium vivax | glycylpeptide N-tetradecanoyltransferase, putative | 0.201725 | 1 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Schistosoma mansoni | protein kinase | 0.0249182 | 0.0923627 | 0.0923627 |
Entamoeba histolytica | SH2-protein kinase domain containing protein | 0.0112272 | 0.0220802 | 0.0220802 |
Schistosoma mansoni | proto-oncogene tyrosine-protein kinase src | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus multilocularis | tyrosine protein kinase Src64B | 0.0112272 | 0.0220802 | 0.0220802 |
Schistosoma mansoni | protein kinase | 0.0249182 | 0.0923627 | 0.0923627 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.201725 | 1 | 1 |
Echinococcus multilocularis | tyrosine protein kinase ABL1 | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus multilocularis | proto oncogene tyrosine protein kinase LCK | 0.0112272 | 0.0220802 | 0.0220802 |
Schistosoma mansoni | tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Plasmodium falciparum | glycylpeptide N-tetradecanoyltransferase | 0.201725 | 1 | 1 |
Echinococcus multilocularis | tyrosine protein kinase shark | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus granulosus | tyrosine protein kinase Src64B | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus granulosus | tyrosine protein kinase Lyn | 0.0112572 | 0.022234 | 0.022234 |
Loa Loa (eye worm) | hypothetical protein | 0.0248882 | 0.092209 | 0.0868093 |
Onchocerca volvulus | 0.0112272 | 0.0220802 | 0.5 | |
Echinococcus multilocularis | tyrosine protein kinase Src42A | 0.0112272 | 0.0220802 | 0.0220802 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Onchocerca volvulus | 0.0112272 | 0.0220802 | 0.5 | |
Echinococcus granulosus | tyrosine protein kinase Fps85D | 0.0112272 | 0.0220802 | 0.0220802 |
Schistosoma mansoni | tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus multilocularis | tyrosine protein kinase lyn lyn a protein tyrosine kinase lymphocyte specific protein tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Giardia lamblia | CDC72 | 0.201725 | 1 | 0.5 |
Echinococcus granulosus | c src tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Trypanosoma cruzi | N-myristoyl transferase, putative | 0.201725 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus granulosus | tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Onchocerca volvulus | 0.0112272 | 0.0220802 | 0.5 | |
Echinococcus granulosus | tyrosine protein kinase Srms | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus granulosus | tyrosine protein kinase shark | 0.0112272 | 0.0220802 | 0.0220802 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Schistosoma mansoni | tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Loa Loa (eye worm) | SRC-1 | 0.0112272 | 0.0220802 | 0.0162634 |
Brugia malayi | N-myristoyltransferase 2 | 0.201725 | 1 | 1 |
Echinococcus multilocularis | c src tyrosine kinase | 0.0112272 | 0.0220802 | 0.0220802 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.00810777 | 0.00606673 | 0.00606673 |
Leishmania major | N-myristoyl transferase, putative | 0.201725 | 1 | 1 |
Echinococcus granulosus | tyrosine protein kinase ABL1 | 0.0112272 | 0.0220802 | 0.0220802 |
Echinococcus granulosus | tyrosine protein kinase Src42A | 0.0112272 | 0.0220802 | 0.0220802 |
Loa Loa (eye worm) | TK/ABL protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Echinococcus granulosus | tyrosine protein kinase Fyn | 0.0112272 | 0.0220802 | 0.0220802 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Onchocerca volvulus | 0.0112272 | 0.0220802 | 0.5 | |
Echinococcus granulosus | proto oncogene tyrosine protein kinase LCK | 0.0112272 | 0.0220802 | 0.0220802 |
Loa Loa (eye worm) | TK protein kinase | 0.0112272 | 0.0220802 | 0.0162634 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 40 Zone units | Growth inhibition of mouse PO3 cells assessed as zone units at 50 ug/disk by disk diffusion agar colony formation assay | ChEMBL. | 9514009 |
Activity (functional) | = 60 Zone units | Growth inhibition of mouse C38 cells assessed as zone units at 50 ug/disk by disk diffusion agar colony formation assay | ChEMBL. | 9514009 |
Activity (functional) | = 100 Zone units | Growth inhibition of human CX-1 cells assessed as zone units at 50 ug/disk by disk diffusion agar colony formation assay | ChEMBL. | 9514009 |
Activity (functional) | = 110 Zone units | Growth inhibition of mouse L1210 cells assessed as zone units at 50 ug/disk by disk diffusion agar colony formation assay | ChEMBL. | 9514009 |
Activity (functional) | = 110 Zone units | Growth inhibition of mouse P388 cells assessed as zone units at 50 ug/disk by disk diffusion agar colony formation assay | ChEMBL. | 9514009 |
GI50 (functional) | = 0.43 uM | Growth inhibition of human SK-MEL-28 cells | ChEMBL. | 9514009 |
GI50 (functional) | = 1.11 uM | Growth inhibition of human IGROV1 cells | ChEMBL. | 9514009 |
GI50 (functional) | = 1.77 uM | Growth inhibition of human HL-60(TB) cells | ChEMBL. | 9514009 |
GI50 (functional) | = 2.17 uM | Growth inhibition of human LOXIMVI cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human MOLT4 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human A549 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human EKVX cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human HOP62 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human HOP92 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human NCI-H226 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human NCI-H23 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human NCI-H322M cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human NCI-H460 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human COLO205 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human HCC2998 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human HCT116 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human HCT15 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human HT-29 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human KM12 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human SW620 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human SF268 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human SF295 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human SF539 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human SNB19 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human SNB75 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human U251 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human M14 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human SK-MEL-2 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human SK-MEL-5 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human UACC257 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human OVCAR-3 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human OVCAR4 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human OVCAR5 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human OVCAR8 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human SKOV3 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human 786-0 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human A498 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human ACHN cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human Caki1 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human RFX393 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human SN12C cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human TK10 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human UO31 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human PC3 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human MCF7 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human MDA-MB-231 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human MDA-MB-435 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human MDA-N cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human BT549 cells | ChEMBL. | 9514009 |
GI50 (functional) | > 5 uM | Growth inhibition of human T47D cells | ChEMBL. | 9514009 |
IC50 (ADMET) | = 3 uM | Cytotoxicity against human HBL100 cells after 72 hrs by MTT assay | ChEMBL. | 23977995 |
IC50 (functional) | = 3 uM | Cytotoxicity against mouse B16F10 cells after 72 hrs by MTT assay | ChEMBL. | 23977995 |
IC50 (functional) | = 5.6 uM | Antimalarial activity against chloroquine resistant Plasmodium falciparum W2 after 72 hrs by LDH assay | ChEMBL. | 26965857 |
IC50 (ADMET) | = 26 uM | Cytotoxicity against human NHDF cells after 72 hrs by MTT assay | ChEMBL. | 23977995 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 23977995 | |
Homo sapiens | ChEMBL23 | 23977995 | |
Plasmodium falciparum | ChEMBL23 | 26965857 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.